Cell and molecular profiles in peripheral nerves shift toward inflammatory phenotypes in diabetic peripheral neuropathy
Journal of Clinical Investigation · 15.10.2025 · 135 (20)
DOI: 10.1172/jci184075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 19.08.2025. Verfasst von Diana Tavares-Ferreira und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Center for Advanced Pain Studies, University of Texas at Dallas, Richardson, Texas, USA. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Sural Nerve, Transcriptome, Tibial Nerve. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NINDS.
Abstract (Originalsprache)
Diabetic peripheral neuropathy (DPN) is a prevalent complication of diabetes mellitus caused by metabolic toxicity to peripheral axons. We aimed to gain deep mechanistic insight into the disease using transcriptomics on tibial and sural nerves recovered from lower leg amputations in a mostly diabetic population and control sural nerves from cross-facial nerve graft surgery. First, comparing DPN versus control sural nerves revealed inflammatory activation and sensory changes in DPN. Second, when comparing mixed sensory and motor tibial and purely sensory sural nerves, we identified key pathway differences in affected DPN nerves, with distinct immunological features observed in sural nerves. Third, spatial transcriptomics of sural nerves revealed shifts in immune cell types associated with axonal loss progression. We also found clear evidence of neuronal transcript changes, like PRPH , in nerves with axonal loss, suggesting perturbed RNA transport into distal sensory axons. This motivated further investigation into neuronal mRNA localization in peripheral nerve axons, generating evidence of robust localization of mRNAs such as SCN9A and TRPV1 in human sensory axons. Our work provides insight into altered cellular and transcriptomic profiles in human nerves in DPN and highlights sensory axon mRNA transport as a potential contributor to nerve degeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience and Center for Advanced Pain Studies, University of Texas at Dallas, Richardson, Texas, USA.
- Department of Neurology, Division of Neuromuscular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Orthopedic Surgery and.
- Department of Plastic Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.
Förderung
- NINDS NIH HHS
- NINDS
Zitieren
APA
Tavares-Ferreira, D., Shen, B. Q., Mwirigi, J. M., Shiers, S., Sankaranarayanan, I., Sreerangapuri, A., Kotamarti, M. B., Inturi, N. N., Mazhar, K., Ubogu, E. E., Thomas, G. L., Lalli, T., Rozen, S. M., Wukich, D. K., & Price, T. J. (2025). Cell and molecular profiles in peripheral nerves shift toward inflammatory phenotypes in diabetic peripheral neuropathy. Journal of Clinical Investigation, 135(20). https://doi.org/10.1172/jci184075
Vancouver
Tavares-Ferreira D, Shen BQ, Mwirigi JM, Shiers S, Sankaranarayanan I, Sreerangapuri A, et al. Cell and molecular profiles in peripheral nerves shift toward inflammatory phenotypes in diabetic peripheral neuropathy. Journal of Clinical Investigation. 2025;135(20). doi:10.1172/jci184075
BibTeX
@article{TavaresFerreira2025,
author = {Tavares-Ferreira, Diana and Shen, Breanna Q and Mwirigi, Juliet M and Shiers, Stephanie and Sankaranarayanan, Ishwarya and Sreerangapuri, Akshitha and Kotamarti, Miriam B and Inturi, Nikhil N and Mazhar, Khadijah and Ubogu, Eroboghene E and Thomas, Geneva L and Lalli, Trapper and Rozen, Shai M and Wukich, Dane K and Price, Theodore J},
title = {Cell and molecular profiles in peripheral nerves shift toward inflammatory phenotypes in diabetic peripheral neuropathy},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {20},
doi = {10.1172/jci184075}
}
EUVIMED